Generix SA develops SaaS based supply chain solutions worldwide. The company's supply chain hub platform offers supply chain execution solutions, including warehouse management software; transport management software to reduce transport costs and associated administrative charges; warehouse management system software; yard management software; and logistics order management system software. Its supply chain hub platform also provides B2B integration solutions, such as EDI services, invoice services solution, AP automation solution, and archive services; and collaboration and visibility solutions comprising supplier, customer, carrier transport, third-party logistics providers (3PL) portals, as well as stock replenishment software, order tracking solutions, and onboarding services, as well as collaborative network. In addition, the company offers sales marketing orchestration; local POS; and TradeXpress, a B2B integration software. It serves food, beverage, pharmaceutical, automotive, aerospace, consumer packaged goods, retail/multi-channel, e-commerce, and logistic industries. The company was founded in 1990 and is headquartered in Lesquin, France. As of August 19, 2022, Generix SA operates as a subsidiary of New Gen Holding SAS.
Research context
Generix SA appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Information Technology
- Industry
- Software
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Generix SA is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.
From a valuation standpoint, the stock is 28.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 2.5.
Generix SA's total revenue sank by 0.0% to $20M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 117.8% to $150K since the same quarter in the previous year.
Based on the above factors, Generix SA gets an overall score of 3/5.